{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:19:35Z","timestamp":1780661975942,"version":"3.54.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>To evaluate the efficacy and safety of platelet-rich plasma (PRP) in the treatment of CTS by meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Wanfang database, CNKI, VIP database, China Biological Literature Database, PubMed, Embase and Cochrane were searched for RCTS about PRP in the treatment of patients with CTS published up to October 2024. The PRP treatment group was treated with PRP on the basis of conventional treatment for CTS. The control group was treated with conventional conservative treatment of CTS. The main evaluation index of meta-analysis was BCTQ severity score. The secondary outcome measures were cross-sectional area of the median nerve, SNCV, DML, and VAS of pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 7 studies involving 365 patients were included in this meta-analysis. There were 183 patients in PRP group and 182 patients in control group. The results of meta-analysis showed that compared with the conventional treatment group, the PRP group had significant reductions in the symptom severity scale at 1, 3, and 6 months and the functional status scale at 3 and 6 months (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). Compared with the conventional treatment group, PRP group increased the cross-sectional area of median nerve at 1 month but decreased the cross-sectional area of median nerve at 3 and 6 months, and the differences were not statistically significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&gt;\u2005.05). The Sensory nerve conduction velocity of PRP treatment group was lower than that of conventional control group at 1 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.0001), 3 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.35) and 6 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.69) months after treatment. Compared with the conventional treatment group, the PRP treatment group increased distal motor latency at 1, 3, and 6 months, but the difference was not statistically significant. Compared with the conventional control group, the PRP treatment group decreased the visual analogue scale of pain at 1 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.56) and 3 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.02) months. There were no serious adverse reactions after PRP treatment in the 4 studies which recorded adverse reactions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>PRP is a safe and effective treatment for patients with CTS. PRP can improve the subjective efficacy of patients with CTS but has little effect on the cross-sectional area of median nerve, SNCV, and DML.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000045010","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:02:06Z","timestamp":1763571726000},"page":"e45010","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of platelet-rich plasma in the treatment of carpal tunnel syndrome: A meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5908-354X","authenticated-orcid":false,"given":"Yali","family":"Du","sequence":"first","affiliation":[{"name":"The Sixth Medical Center, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Jiang","sequence":"additional","affiliation":[{"name":"The Sixth Medical Center, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaifei","family":"Fu","sequence":"additional","affiliation":[{"name":"The Sixth Medical Center, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwen","family":"Cui","sequence":"additional","affiliation":[{"name":"The Fourth Medical Center, Chinese PLA General Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260520","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1212\/WNL.58.2.289","article-title":"Carpal tunnel syndrome incidence in a general population.","volume":"58","author":"Mondelli","year":"2002","journal-title":"Neurology"},{"key":"R2-20260520","first-page":"6","article-title":"Carpal tunnel syndrome.","volume":"77","author":"Aroori","year":"2008","journal-title":"Ulster Med J"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC201509010","article-title":"In the clinic. carpal tunnel syndrome.","volume":"163","author":"Kleopa","year":"2015","journal-title":"Ann Intern Med"},{"key":"R4-20260520","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJMcp013018","article-title":"Clinical practice. Carpal tunnel syndrome.","volume":"346","author":"Katz","year":"2002","journal-title":"N Engl J Med"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1474-4422(16)30231-9","article-title":"Carpal tunnel syndrome: clinical features, diagnosis, and management.","volume":"15","author":"Padua","year":"2016","journal-title":"Lancet Neurol"},{"key":"R6-20260520","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.pmr.2018.06.009","article-title":"Guiding treatment for carpal tunnel syndrome.","volume":"29","author":"Wang","year":"2018","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"R7-20260520","first-page":"CD010003","article-title":"Splinting for carpal tunnel syndrome.","volume":"2","author":"Karjalainen","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-20260520","first-page":"CD009899","article-title":"Exercise and mobilisation interventions for carpal tunnel syndrome.","volume":"2012","author":"Page","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R9-20260520","first-page":"CD001554","article-title":"Local corticosteroid injection for carpal tunnelsyndrome.","volume":"2","author":"Marshall","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.apmr.2019.04.016","article-title":"Ultrasound-guided standard vs dual-target subacromial corticosteroid injections for shoulder impingement syndrome: a randomized controlled trial.","volume":"100","author":"Wang","year":"2019","journal-title":"Arch Phys Med Rehabil"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ana.25332","article-title":"Randomized double-blinded clinical trial of 5% dextrose versus triamcinolone injection for carpal tunnel syndrome patients.","volume":"84","author":"Wu","year":"2018","journal-title":"Ann Neurol"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/term.2815","article-title":"Short-term effectiveness of platelet-rich plasma in carpal tunnel syndrome: a controlled study.","volume":"13","author":"G\u00fcven","year":"2019","journal-title":"J Tissue Eng Regen Med"},{"key":"R13-20260520","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.apmr.2020.12.025","article-title":"One-year efficacy of platelet-rich plasma for moderate-to-severe carpal tunnel syndrome: a prospective, randomized, double-blind, controlled trial.","volume":"102","author":"Chen","year":"2021","journal-title":"Arch Phys Med Rehabil"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1007\/s10067-019-04719-7","article-title":"Platelet-rich plasma in treatment of patients with idiopathic carpal tunnel syndrome.","volume":"38","author":"Senna","year":"2019","journal-title":"Clin Rheumatol"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/term.2950","article-title":"Comparison of perineural platelet-rich plasma and dextrose injections for moderate carpal tunnel syndrome: a prospective randomized, single-blind, head-to-head comparative trial.","volume":"13","author":"Shen","year":"2019","journal-title":"J Tissue Eng Regen Med"},{"key":"R16-20260520","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41598-017-00224-6","article-title":"Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial.","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"R17-20260520","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/2000656X.2016.1260025","article-title":"Platelet-rich plasma versus corticosteroid injections for carpal tunnel syndrome.","volume":"51","author":"Uzun","year":"2017","journal-title":"J Plast Surg Hand Surg"},{"key":"R18-20260520","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s41983-020-00184-1","article-title":"Comparison of efficiency between platelet rich plasma and corticosteroid injection therapies in patients with Carpal tunnel syndrome: a prospective randomized controlled study.","volume":"56","author":"Hashim","year":"2020","journal-title":"Egyptian J Neurol Psychiatry Neurosurg"},{"key":"R19-20260520","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10815-018-1130-8","article-title":"In vitro evidence that platelet-rich plasma stimulates cellular processes involved in endometrial regeneration.","volume":"35","author":"Aghajanova","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"R20-20260520","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jca.20275","article-title":"Hematopoietic progenitor cell count, but not immature platelet fraction value, predicts successful harvest of autologous peripheral blood stem cells.","volume":"26","author":"Mitani","year":"2011","journal-title":"J Clin Apher"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12035-013-8494-7","article-title":"Platelet-rich plasma and the elimination of neuropathic pain.","volume":"48","author":"Kuffler","year":"2013","journal-title":"Mol Neurobiol"},{"key":"R22-20260520","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/mus.23863","article-title":"Platelet-rich plasma limits the nerve injury caused by 10% dextrose in the rabbit median nerve.","volume":"49","author":"Park","year":"2014","journal-title":"Muscle Nerve"},{"key":"R23-20260520","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ijom.2008.05.010","article-title":"Platelet rich plasma may enhance peripheral nerve regeneration after cyanoacrylate reanastomosis: a controlled blind study on rats.","volume":"37","author":"Elgazzar","year":"2008","journal-title":"Int J Oral Maxillofac Surg"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/lary.20860","article-title":"Effect of neural-induced mesenchymal stem cells and platelet-rich plasma on facial nerve regeneration in an acute nerve injury model.","volume":"120","author":"Cho","year":"2010","journal-title":"Laryngoscope"},{"key":"R25-20260520","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41536-020-00101-3","article-title":"Ultrasound-guided platelet-rich plasma injection and multimodality ultrasound examination of peripheral nerve crush injury.","volume":"5","author":"Zhu","year":"2020","journal-title":"NPJ Regen Med"},{"key":"R26-20260520","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jocn.2017.06.053","article-title":"Ultrasound-guided perineural injection with platelet-rich plasma improved the neurophysiological parameters of carpal tunnel syndrome: a case report.","volume":"44","author":"Kuo","year":"2017","journal-title":"J Clin Neurosci"},{"key":"R27-20260520","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0042-1744410","article-title":"Electromyographic and clinical investigation of the effect of platelet-rich plasma on peripheral nerve regeneration in patients with diabetes after surgery for carpal tunnel syndrome.","volume":"49","author":"Yasak","year":"2022","journal-title":"Arch Plast Surg"},{"key":"R28-20260520","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12891-018-1963-4","article-title":"Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial.","volume":"19","author":"Raeissadat","year":"2018","journal-title":"BMC Musculoskelet Disord"},{"key":"R29-20260520","doi-asserted-by":"crossref","first-page":"834213","DOI":"10.3389\/fphar.2022.834213","article-title":"Effectiveness of platelet-rich plasma for patients with carpal tunnel syndrome: a systematic review and meta-analysis of current evidence in randomized controlled trials.","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Pharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:03:20Z","timestamp":1779275000000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":29,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045010","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2024-12-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}